Of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat
JOURNAL OF VIROLOGY, June 1989, p. 2585-2591 Vol. 63, No. 6 0022-538X/89/062585-07$02.00/0 Copyright © 1989, American Society for Microbiology Role of SPi-Binding Domains in In Vivo Transcriptional Regulation of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat DAVID HARRICH, JOSEPH GARCIA, FOON WU, RONALD MITSUYASU, JOSEPH GONZALEZ, AND RICHARD GAYNOR* Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of California, Los Angeles, and Wadsworth Veterans Hospital, Los Angeles, California 90024 Received 13 December 1988/Accepted 1 March 1989 Five regions of the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) have been shown to be important in the transcriptional regulation of HIV in HeLa cells. These include the negative regulatory, enhancer, SP1, TATA, and TAR regions. Previous studies in which purified SP1 was used showed that the three SPl-binding sites in the HIV LTR were important in the in vitro transcription of this promoter. However, no studies to ascertain the role of each of these SPl-binding sites in basal and tat-induced transcriptional activation in vivo have been reported. To determine the role of SP1 sites in transcriptional regulation of the HIV LTR in vivo, these sites were subjected to oligonucleotide mutagenesis both individually and in groups. The constructs were tested by DNase I footprinting with both oligonucleotide affinity column-purified SP1 and partially purified HeLa extract and by chloramphenicol acetyltransferase assays in both the presence and absence of the tat gene. Mutagenesis of each SPl-binding site resulted in minimal changes in basal and tat-induced transcriptional activation.
[Show full text]